Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Liquid Biopsy|July 21, 2025
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral bloodCaterina De Rosa, Luisa Amato, Annalisa Ariano, et al.
Biomedicines|April 27, 2024
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung CancerCaterina De Rosa, Francesca Iommelli, Viviana De Rosa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2021
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkersRiccardo Lobefaro, Giuseppe Viscardi, Raimondo Di Liello, et al.
Journal of Translational Medicine|November 24, 2022
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLCCarminia Maria Della Corte, Vincenza Ciaramella, Kavya Ramkumar, et al.
Thoracic Cancer|August 21, 2025
Rescue Surgery for Advanced Stage Lung Cancer: A Systematic ReviewBeatrice Leonardi, Gaetana Messina, Giuseppe Vicario, et al.
ESC Heart Failure|April 1, 2022
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patientsAlessandra Cuomo, Valentina Mercurio, Gilda Varricchi, et al.
Medical Oncology (Northwood, London, England)|February 11, 2021
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotypeDavide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone, et al.
Diagnostics (Basel, Switzerland)|February 11, 2023
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer PatientsValerio Nardone, Alfonso Reginelli, Giuseppina De Marco, et al.
Molecular Cancer Therapeutics|March 3, 2019
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal CancerGiulia Martini, Claudia Cardone, Pietro Paolo Vitiello, et al.
Cancers|October 11, 2019
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution ExperiencePietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta, et al.
Pageof 16